Tenders Are Invited For acquisition of medicines for human use, intended to meet the demands of pharmaceutical care and health units linked to primary care

1 caramazepinacaramazepine, dosage 20 mgml, presentation Oral Suspension Differentiated Treatment: Type I Exclusive Participation of MEEPPEquipped Applicaility Decree 7174: Non APPLICAILITY PREFERENCE Margin: Non QUANTITY: 5000 supply unit: ottle 10000 ml2 chloridochlonidine hydrochloride, 01 mramentation Differentiated: Type I Exclusive MEEPPEQUIPMENT PARTICIPATION APPLICAILITY DECREE 7174: Non APPLICAILITY PREFERENCE Margin: Non QUANTITY: 270000 SUPPLY UP: compressed3 erythromycinAeritromycin, Stolard Presentation, Concentration 50 mgML, Use Oral Treatement Differentiated: Type I Exclusive Participation of MEEPPEquipped Applicaility Decree 7174: Non Applicaility Preference Margin: Non QUANTITY: 5000 Supply Unit: ottle 6000 ml4 Gentamycinagentamycin, SALFATE SALF, 5 MGML, DIFFERENTIATED OFTATE SOLUTION: Type I Part EXCLUSIVE IMPPEAL OF MEEPPEQUIPPED APPLICAILITY DECREE 7174: NON APPLICAILITY PREFERENCE Margin: Non QUANTITY: 3000 supply unit: vial 500 ml5 Aluminum hydroxide Aluminum hydroxide, liquid physical appearance, al (OH) 3, molecular weight 78, 00 gmol, degree of purity 2, additional characteristic colloidal suspension (gel), chemical reference numer CAS 21645512 Differentiated treatment: Type Iexclusive participation of MEEPPEquipped Applicaility Decree 7174: nonapplicaility preference margin margin : Non Quantity: 5000 Supply Unit: MILILITRO